Nirmal Bang

Nirmal Bang, one of the leading stock broking companies in India, caters to retail and institutional clients by offering them a range of financial products and services, including equities, derivatives, commodities, currency derivatives, mutual funds, IPOs, insurance, depository services and PMS.

Nirmal Bang is drawn from a diversity of professional backgrounds, and blend of experience, skill and dedication is shared with its clients. Nirmal Bang emphasizes adequate, thorough research local and world-wide developments, balancing these with the astute discovery of intrinsic values, synergies and growth. The aim is simply to help the investors to maximize their returns.

A Relationship Beyond Broking

External broker reports(aggregated public sources), Nirmal Bang

External broker reports(aggregated public sources)

Equity Bottom-Up

<div><div><div><div><ul><li>ROSSARI has taken some price hikes from March’22 in order to cope with the ongoing inflationary challenges.</li><li>Formulations business is the core strength of ROSSARI’s business model and inability to pass on the cost impact would mean margin pressure for two more quarters</li></ul><ul style="list-style-type: none;"><li> </li></ul></div></div></div></div><div><div><div><div><ul><li>On a consolidated basis, the management has guided for Rs20bn revenue and Rs2.5bn EBITDA for FY23.</li></ul></div></div></div></div><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

ROSSARI has taken some price hikes from March’22 in order to cope with the ongoing inflationary challenges.Formulations business is the core strength of ROSSARI’s business model and inability to pass on the cost impact would mean margin pressure for two more quarters On a consolidated basis, the management has guided for Rs20bn revenue and Rs2.5bn EBITDA for FY23.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Rossari Biotech: Complete Pass-Through Is a Challenge in Formulations Biz